Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #4
mi
from
Santa Monica, CA
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #4
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #5
mi
from
Coral Gables, FL
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #5
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #6
mi
from
Tampa, FL
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #6
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #7
mi
from
West Palm Beach, FL
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #7
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #8
mi
from
Alpharetta, GA
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #8
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #9
mi
from
New York, NY
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #9
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #10
mi
from
Franklin, TN
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #10
mi
from
Franklin, TN
Click here to add this to my saved trials
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated:  12/31/1969
Endo Clinical Trial Site #11
mi
from
Austin, TX
Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Status: Enrolling
Updated: 12/31/1969
Endo Clinical Trial Site #11
mi
from
Austin, TX
Click here to add this to my saved trials
The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease
The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Women's Heart Center
mi
from
Los Angeles, CA
The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease
The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Women's Heart Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Reproductive Hormones And Pre-Clinical Cardiovascular Disease (CVD) In Women
Reproductive Hormones And Pre-Clinical CVD In Women
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Reproductive Hormones And Pre-Clinical Cardiovascular Disease (CVD) In Women
Reproductive Hormones And Pre-Clinical CVD In Women
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
Prolonged Sitting on Responses to Short-Term Exercise Training
Effect of Prolonged Sitting on Metabolic and Cardiovascular Responses to Short-Term Exercise Training
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Prolonged Sitting on Responses to Short-Term Exercise Training
Effect of Prolonged Sitting on Metabolic and Cardiovascular Responses to Short-Term Exercise Training
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health Systems
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Spectrum Health Hospitals
mi
from
Grand Rapids, MI
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Spectrum Health Hospitals
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
New York Langone Medical Center
mi
from
New York, NY
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
New York Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
St. Francis Hospital
mi
from
Roslyn, NY
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
St. Francis Hospital
mi
from
Roslyn, NY
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Riverside Methodist Hospital
mi
from
Columbus, OH
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Riverside Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Pinnacle Health/Moffitt Heart and Vascular Institute
mi
from
Harrisburg, PA
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health/Moffitt Heart and Vascular Institute
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Baylor Heart and Vascular Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated:  12/31/1969
Aurora Health Care, St. Luke's Medical Center
mi
from
Milwaukee, WI
Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)
Medtronic CoreValve Evolut R United States Clinical Study (Evolut 34R Addendum)
Status: Enrolling
Updated: 12/31/1969
Aurora Health Care, St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Local Institution
mi
from
Nagoya-shi,
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Local Institution
mi
from
Nagoya-shi,
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Inova Heart and Vascular Institute
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Northwestern Medicine
mi
from
Chicago, IL
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Northwestern Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Orange County Research Center
mi
from
Tustin, CA
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Duke Advanced Heart and Lung Failure Clinic
mi
from
Durham, NC
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Duke Advanced Heart and Lung Failure Clinic
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Cross-over Phase 2 Study of Continuous 5-Hour Intravenous Infusions of BMS-986231 in Patients With Heart Failure and Impaired Systolic Function
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Anniston, AL
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Port Orange, FL
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Port Orange, FL
Click here to add this to my saved trials
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
A Phase 2a Randomized, Blinded, Placebo-controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias
Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias
Apple Heart Study: Assessment of Wristwatch-Based Photoplethysmography to Identify Cardiac Arrhythmias
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Foothill Cardiology
mi
from
Pasadena, CA
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Foothill Cardiology
mi
from
Pasadena, CA
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Holy Cross Medical Group
mi
from
Coral Springs, FL
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Holy Cross Medical Group
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Charlotte Heart Group
mi
from
Port Charlotte, FL
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Charlotte Heart Group
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Atlanta Institute For Medical Research, Inc
mi
from
Atlanta, GA
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Atlanta Institute For Medical Research, Inc
mi
from
Atlanta, GA
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Atlanta Heart Specialists, LLC
mi
from
Cumming, GA
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Atlanta Heart Specialists, LLC
mi
from
Cumming, GA
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Research of Northwest Indiana, LLC
mi
from
Munster, IN
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Research of Northwest Indiana, LLC
mi
from
Munster, IN
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Research Integrity, Llc
mi
from
Owensboro, KY
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Research Integrity, Llc
mi
from
Owensboro, KY
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Ochsner Health System
mi
from
New Orleans, LA
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Ochsner Health System
mi
from
New Orleans, LA
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Penobscot Bay Medical Center
mi
from
Rockport, ME
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Penobscot Bay Medical Center
mi
from
Rockport, ME
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Endeavor Medical Research
mi
from
Alpena, MI
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Endeavor Medical Research
mi
from
Alpena, MI
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Great Lakes Heart and Vascular Institute PC
mi
from
Saint Joseph, MI
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Great Lakes Heart and Vascular Institute PC
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
HealthEast Medical Research Institute
mi
from
Saint Paul, MN
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
HealthEast Medical Research Institute
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Jackson Heart Clinic
mi
from
Jackson, MS
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Jackson Heart Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Associates of the Delaware Valley
mi
from
Elmer, NJ
Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Associates of the Delaware Valley
mi
from
Elmer, NJ
Click here to add this to my saved trials